BORTYZ 3,5 MG PO LIOF INJ CT FA VD TRANS

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1553700370011
  • GGREM 538015020016403
  • Código de barras 7898577810923

O que a fonte publica

Detentor do registro
ACCORD FARMACÊUTICA LTDA
Princípios ativos
BORTEZOMIBE
Embalagem
3,5 MG PO LIOF INJ CT FA VD TRANS
Tipo de produto
Similar
Classe terapêutica
L1J - ANTINEOPLÁSICOS INIBIDORES DE PROTEASSOMA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:538015020016403
{
  "name": "BORTYZ 3,5 MG PO LIOF INJ CT FA VD TRANS",
  "holder": "ACCORD FARMACÊUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7898577810923"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "538015020016403",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "64.171.697/0001-46",
  "priceRegime": "Regulado",
  "productName": "BORTYZ",
  "productType": "Similar",
  "hospitalOnly": true,
  "presentation": "3,5 MG PO LIOF INJ CT FA VD TRANS",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "3339.55",
    "icms-12": "3794.94",
    "icms-17": "4023.55",
    "icms-18": "4072.62",
    "icms-19": "4122.90",
    "icms-20": "4174.44",
    "icms-21": "4227.28",
    "icms-22": "4281.47",
    "icms-23": "4337.08",
    "icms-17.5": "4047.94",
    "icms-19.5": "4148.51",
    "icms-20.5": "4200.69",
    "icms-22.5": "4309.10",
    "icms-12-alc": "3749.40",
    "icms-17-alc": "3975.27",
    "icms-18-alc": "4023.75",
    "icms-19-alc": "4073.43",
    "icms-20-alc": "4124.34",
    "icms-21-alc": "4176.55",
    "icms-22-alc": "4230.09",
    "icms-23-alc": "4285.03",
    "withoutTaxes": "3299.48",
    "icms-17.5-alc": "3999.36",
    "icms-19.5-alc": "4098.73",
    "icms-20.5-alc": "4150.28",
    "icms-22.5-alc": "4257.39"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "BORTEZOMIBE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "BORTEZOMIBE"
  ],
  "therapeuticClass": "L1J - ANTINEOPLÁSICOS INIBIDORES DE PROTEASSOMA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1553700370011",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1J",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:538015020016403"